Pricing Log in Create free account

Alpha Cognition Inc. (ACOG) vs Atrium Therapeutics, Inc. (RNA)

Alpha Cognition Inc. and Atrium Therapeutics, Inc. are both Biotechnology companies. Alpha Cognition Inc. and Atrium Therapeutics, Inc. are of similar size ($185.8M and $180.5M). Alpha Cognition Inc. has the higher net margin (−137.7% vs −203.7%) and the lower return on invested capital (−144.7% vs 0.00%). Across the 14 metrics below, Alpha Cognition Inc. leads on 7 and Atrium Therapeutics, Inc. on 7.

Valuation

Metric ACOG RNA Biotechnology median
P/E n/m n/m 10.60
P/S 11.83 5.08 9.40
P/B 3.41 0.66 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 2.03 0.66
EV/Sales 9.18 (4.33) 9.02
Earnings yield (11.58%) (40.03%) (32.88%)
Free cash flow yield (20.54%) (40.71%) (23.13%)

Profitability

Metric ACOG RNA Biotechnology median
Gross margin 90.37% 100.00% 68.51%
Operating margin (174.70%) (214.60%) 0.00%
Net margin (137.69%) (203.67%) 0.00%
Free cash flow margin (242.99%) (206.99%) 0.00%
Return on equity (49.53%) 0.00% (51.96%)
Return on assets (38.33%) (40.74%) (46.06%)
Return on invested capital (144.65%) 0.00% 0.00%

Growth

Metric ACOG RNA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 42.08% — 29.88%
Revenue growth, 5-year CAGR — 22.54% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACOG RNA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.03 8.73 4.97
Net debt to EBITDA 2.92 9.08 1.01

Dividend

Metric ACOG RNA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ACOG RNA Biotechnology median
Market cap 180.54m 185.78m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack